Therapy News and Research

RSS

Niclosamide drug effective against colon cancer metastasis

A compound that for about 60 years has been used as a drug against tapeworm infection is also apparently effective against colon cancer metastasis, as studies using mice have now shown.

18 Jun 2011

Encouraging results from ReShape Duo Phase 1 study for treatment of obesity

ReShape Medical, Inc. today announces results of its U.S. Phase 1 investigational clinical study. This feasibility study of thirty subjects assessed the safety and effectiveness of the ReShape Duo in conjunction with lifestyle modification in patients with a body mass index of 30-40.

17 Jun 2011

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

Evaluating patients with multiple sclerosis who have narrowed jugular and azygos veins-and the value of widening those veins with angioplasty-warrants careful, well-designed research, noted members of a Society of Interventional Radiology Foundation's Research Consensus Panel.

17 Jun 2011

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Allos Therapeutics, Inc. today reported results from a retrospective analysis of data from the Company's pivotal PROPEL trial which suggested that treatment with single-agent FOLOTYN may result in increased response rates and progression-free survival relative to the immediate prior line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.

17 Jun 2011

Nuvilex describes advantages of cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. described today potential advantages of cell encapsulation technology for use in cancer therapies when more than one cancer-fighting drug is used.

17 Jun 2011

Specific lipid mixtures can overcome lethal effects of multidrug-resistant bacteria

"Super bugs," which can cause wide-spread disease and may be resistant to most, if not all, conventional antibiotics, still have their weaknesses. A team of Canadian scientists discovered that specific mixtures of antimicrobial agents presented in lipid (fatty) mixtures can significantly boost the effectiveness of those agents to kill the resistant bacteria.

17 Jun 2011

CTI announces positive results from Phase I-II pixantrone combination study against INHL

Cell Therapeutics, Inc. announced the publication of results posted in the online journal of Cancer of a Phase I-II study that evaluated the safety and efficacy of pixantrone when used in combination with fludarabine, dexamethasone and rituximab replacing mitoxantrone in the standard FND-R regimen with FPD-R among 28 patients with relapsed or refractory indolent non-Hodgkin's lymphoma.

17 Jun 2011

Functional vision restored after 55 years

After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely blind in that eye.

17 Jun 2011

Scientists uncover how immune system responds to invading anthrax bacteria

Scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered how the body's immune system launches its survival response to the notorious and deadly bacterium anthrax.

17 Jun 2011

Key to remove stem cells responsible for fat expansion

Researchers may have found the key to developing a method to rid the body of stem cells responsible for driving fat expansion. According to a report in the June 16 Cell Stem Cell, a Cell Press publication, they've landed the first protein marker on the surface of those so-called adipose stromal cells (ASCs), which serve as progenitors of the cells that make up fat tissue.

17 Jun 2011

Positive results from etanercept pilot study against dermatomyositis

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy.

17 Jun 2011

HRT use linked to decreased risk of peripheral arterial disease in postmenopausal women

A new study presented at the 65th Vascular Annual Meeting of the Society of Vascular Surgery found that the use of HRT in postmenopausal women is associated with a significant reduction in the prevalence of peripheral arterial disease.

17 Jun 2011

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that can cause vision loss.

17 Jun 2011

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.

16 Jun 2011

Adaptimmune melanoma trial opening

Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri.

16 Jun 2011

Low testosterone linked to varicoceles

As many as 15 percent of men have varicoceles, masses of enlarged and dilated veins in the testicles. There is new evidence that varicoceles, long known to be a cause of male infertility, interfere with the production of testosterone -- a crucial hormone to maintaining men's health. There is good news too: Microsurgery can increase testosterone levels in these men. Results of new research by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are in a recent edition of BJU International.

16 Jun 2011

Ankota introduces TherapEZ web-based, mobile tablet-based solution for home health therapy agencies

Ankota, the developer of the first Healthcare Delivery Management (HDM) solutions, introduced today its TherapEZ software as a solution for streamlining many of the operational issues faced by home health therapy agencies as they seek to provide services for patients at home and to coordinate care with home health agencies.

16 Jun 2011

Mary Ann Liebert peer-reviewed journal publishes new clinical guidelines on hyperthyroidism

New clinical guidelines developed by an expert panel that include 100 evidence-based recommendations for optimal care of patients with hyperthyroidism and other causes of thyrotoxicosis are presented in the current issue of Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc.

16 Jun 2011

UCSF study seeks to discover true causes of sudden cardiac death

A new study by the University of California, San Francisco's Cardiac Electrophysiology Service seeks to discover for the first time the true causes of sudden cardiac death (SCD), why it is more prevalent in some demographic populations, and whether it is too often inaccurately cited as a cause of death.

16 Jun 2011

UCLA's new center to explore links between brain, digestive system in chronic disorders

Investigators at UCLA's Center for Neurobiology of Stress have been studying the links between the brain and digestive system in the development and treatment of common chronic digestive disorders in adults and children.

16 Jun 2011

Therapy News and Research

Niclosamide drug effective against colon cancer metastasis

Encouraging results from ReShape Duo Phase 1 study for treatment of obesity

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

Allos Therapeutics reports results from FOLOTYN pivotal trial against peripheral T-cell lymphoma

Nuvilex describes advantages of cell encapsulation technology for multiple cancer therapies

Specific lipid mixtures can overcome lethal effects of multidrug-resistant bacteria

CTI announces positive results from Phase I-II pixantrone combination study against INHL

Functional vision restored after 55 years

Scientists uncover how immune system responds to invading anthrax bacteria

Key to remove stem cells responsible for fat expansion

Positive results from etanercept pilot study against dermatomyositis

HRT use linked to decreased risk of peripheral arterial disease in postmenopausal women

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Adaptimmune melanoma trial opening

Low testosterone linked to varicoceles

Ankota introduces TherapEZ web-based, mobile tablet-based solution for home health therapy agencies

Mary Ann Liebert peer-reviewed journal publishes new clinical guidelines on hyperthyroidism

UCSF study seeks to discover true causes of sudden cardiac death

UCLA's new center to explore links between brain, digestive system in chronic disorders

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News